Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Frederick S Nolte"'
Autor:
Spitzer, Eric D.
Publikováno v:
The Quarterly Review of Biology, 2012 Dec . 87(4), 393-393.
Externí odkaz:
https://www.jstor.org/stable/10.1086/668170
Autor:
David H. Persing, Fred C. Tenover, Yi-Wei Tang, Frederick S. Nolte, Randall T. Hayden, Alex van Belkum
The latest molecular diagnostic techniques presented in one comprehensive volume.
Autor:
Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, Shannon McGue, Braxton Jeffcoat, Jaclyn Dunne, Logan Johnson, Seungho Choi, Georges J. Nahhas, Amy S. Gandy, Nikolina Babic, Frederick S. Nolte, Philip Howe, Besim Ogretmen, Vamsi K. Gangaraju, Stephen Tomlinson, Brian Madden, Tracy Bridges, Patrick A. Flume, John Wrangle, Mark P. Rubinstein, Prabhakar K. Baliga, Satish N. Nadig, Shikhar Mehrotra
Publikováno v:
iScience, Vol 24, Iss 6, Pp 102489- (2021)
Summary: The SARS-CoV-2 viral pandemic has induced a global health crisis, which requires more in-depth investigation into immunological responses to develop effective treatments and vaccines. To understand protective immunity against COVID-19, we sc
Externí odkaz:
https://doaj.org/article/81d3dd2c458348b2ad48c0ed81cf4392
Autor:
Eric D. Spitzer
Publikováno v:
The Quarterly Review of Biology. 87:393-393
Publikováno v:
Open Forum Infectious Diseases. 9
Background Plasma microbial cell-free (mcfDNA) testing has emerged as a promising tool for unbiased detection of pathogens in patients with suspected infections. A systematic evaluation of the patient populations in which this test is used may provid
Autor:
Sarah Y. Park, Eliza J Chang, Nathan Ledeboer, Kevin Messacar, Martin S. Lindner, Shivkumar Venkatasubrahmanyam, Sivan Bercovici, Judith C. Wilber, Marla Lay Vaughn, Bradley A. Perkins, Frederick S. Nolte
Microbial cell-free DNA (mcfDNA) sequencing is an emerging infectious disease diagnostic tool which enables unbiased pathogen detection from plasma. The Karius Test®, a commercial mcfDNA sequencing assay developed by and available since 2017 from Ka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d80e7e1d11f3eafb9887ebc4d41b118
https://doi.org/10.1101/2023.01.03.22283605
https://doi.org/10.1101/2023.01.03.22283605
Autor:
Christopher D. Doern, Melissa B. Miller, Kevin Alby, Michael A. Bachman, Stephen M. Brecher, Aida Casiano-Colon, Marc Roger Couturier, J. Kristie Johnson, James E. Kirby, Erin McElvania, Duane W. Newton, Frederick S. Nolte, Preeti Pancholi, Peggy McNult, Vaishali Dharmarha, Sherry Dunbar
Publikováno v:
J Clin Microbiol
Clinical Microbiology Open (CMO), a meeting supported by the American Society for Microbiology’s Clinical and Public Health Microbiology Committee (CPHMC) and Corporate Council, provides a unique interactive platform for leaders from diagnostic mic
Autor:
Isabella W. Martin, Marc Roger Couturier, Marie-Claire Rowlinson, David R. Peaper, Romney M. Humphries, Frederick S. Nolte, Elitza S. Theel, Rosemary C. She, Daniel D. Rhoads, Patricia J. Simner, Kaede V. Sullivan, Christina Wojewoda
Publikováno v:
Journal of Clinical Microbiology
The U.S. Food & Drug Administration (FDA) regulates the marketing of manufacturers’ in vitro diagnostic tests (IVDs), including assays for the detection of SARS-CoV-2. The U.S. government’s Clinical Laboratory Improvement Amendments (CLIA) of 198
Autor:
Frederick S. Nolte
Publikováno v:
Clinical Chemistry. 66:140-142
Publikováno v:
The Journal of Applied Laboratory Medicine. 3:580-586
Background Procalcitonin (PCT) is a well-established marker for bacterial infection. Recently the US Food and Drug Administration approved the expanded use of this biomarker to guide clinical decisions for antibiotic treatment in patients with lower